J2KBIO Co., Ltd. (KOSDAQ:420570)
7,810.00
-160.00 (-2.01%)
At close: Jun 5, 2026
-26.80% (1Y)
| Market Cap | 45.67B -31.5% |
| Revenue (ttm) | 36.82B +13.0% |
| Net Income | 4.03B +39.4% |
| EPS | 691.15 +36.0% |
| Shares Out | 5.85M |
| PE Ratio | 11.30 |
| Forward PE | n/a |
| Dividend | 250.00 (3.20%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 24,073 |
| Open | 7,970.00 |
| Previous Close | 7,970.00 |
| Day's Range | 7,520.00 - 7,970.00 |
| 52-Week Range | 7,170.00 - 11,850.00 |
| Beta | 0.43 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 12, 2026 |